The Jakarta Composite Index (JCI) today, on Thursday (28/1), has the potential to strengthen.
The Jakarta Composite Index (JCI) closed down 31.00 points or 0.50 percent to 6,109.16 on Wednesday (27/1).
Bank Indonesia forecasts economic growth in 2022 to be in the range of 5.4-5.9%. This year, BI predicts it in the range of 4.8-5.8%.
At the end of the first session trading today, on Wednesday (27/1), the Jakarta Composite Index (JCI) fell 48.37 points or 0.8 percent to 6,091.8.
Trade Minister Muhammad Lutfi said Indonesia could achieve the trade sector growth target of 6.3% this year.
PT Medikaloka Hermina Tbk (HEAL) has completed an additional capital without pre-emptive rights issue (PMTHMETD) or a private placement earlier this year.
The Jakarta Composite Index (JCI) opened up 6.35 points or 0.1 percent to 6,146.52, on Wednesday (27/1).
The United States global financial investor company, General Atlantic (GA), will invest in Kalbe Genexine Biologics (KGBio) for US$ 55 million or the equivalent of Rp774,730 billion as core capital.
Taiheiyo Cement Corporation (TCC) plans to invest in PT Solusi Bangun Indonesia Tbk (SMCB) through a capital investment of US$ 220 million or equivalent to Rp3.098 trillion.
The Jakarta Composite Index (JCI) today, on Wednesday (27/1), is expected to continue to weaken.
PT Bumi Serpong Damai Tbk (BSDE) posted pre-sales or marketing sales of Rp6.5 trillion last year.
PT Damai Sejahtera Abadi Tbk, an electronic and household furniture retailer, will start its trading debut on the Indonesia Stock Exchange (IDX) on Monday (1/2) by selling 457.5 million new shares through an initial public offering.
